Aclidinium bromide improves symptoms and sleep quality in COPD: a pilot study
Authors:
- 22 June 2017
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 49 (6) , 1700485
Abstract
Aclidinium statistically improved symptoms, and sleep and physical activity in moderate COPDhttp://ow.ly/2chV30adLbWKeywords
Funding Information
- Almirall S.A., Barcelona, Spain
This publication has 15 references indexed in Scilit:
- Evaluation of the psychometric properties of the Nighttime Symptoms of COPD InstrumentInternational Journal of Chronic Obstructive Pulmonary Disease, 2015
- Prevalence of night-time dyspnoea in COPD and its implications for prognosisEuropean Respiratory Journal, 2014
- Impact of night-time symptoms in COPD: a real-world study in five European countriesInternational Journal of Chronic Obstructive Pulmonary Disease, 2013
- Rules for Scoring Respiratory Events in Sleep: Update of the 2007 AASM Manual for the Scoring of Sleep and Associated EventsJournal of Clinical Sleep Medicine, 2012
- Sleep quality in chronic obstructive pulmonary diseaseRespirology, 2012
- Efficacy of Aclidinium Bromide 400 μg Twice Daily Compared With Placebo and Tiotropium in Patients With Moderate to Severe COPDChest, 2012
- Night-time symptoms: a forgotten dimension of COPDEuropean Respiratory Review, 2011
- Sleep profile and symptoms of sleep disorders in patients with stable mild to moderate chronic obstructive pulmonary diseaseSleep Medicine, 2011
- Effects of Salmeterol on Sleeping Oxygen Saturation in Chronic Obstructive Pulmonary DiseaseRespiration, 2009
- Physical activity in patients with COPDEuropean Respiratory Journal, 2008